|
|
|
Insider
Information: |
Treu Jesse I |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
24 |
|
Direct
Shares |
55,258 |
|
Indirect Shares
|
2,983,502 |
|
|
Direct
Value |
$34,217 |
|
|
Indirect Value
|
$10,994,341 |
|
|
Total
Shares |
3,038,760 |
|
|
Total
Value |
$11,028,559 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Nuvasive Inc |
NUVA |
10% Owner |
|
0 |
2004-05-18 |
31,204 |
Premium* |
|
Senomyx Inc |
SNMX |
10% Owner |
|
0 |
2004-06-25 |
19,603 |
Premium* |
|
Santarus Inc |
SNTS |
10% Owner |
2004-04-06 |
0 |
2004-04-06 |
64,471 |
Premium* |
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
Director |
2010-06-09 |
0 |
2009-12-18 |
0 |
Premium* |
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
2006-04-18 |
0 |
2006-12-12 |
21,068 |
Premium* |
|
Northstar Neuroscience Inc |
NSTR |
Director |
2007-05-18 |
17,231 |
2007-05-18 |
14,690 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2009-01-30 |
67,875 |
Premium* |
|
Volcano Corp |
VOLC |
10% Owner |
2008-04-24 |
21,289 |
2008-07-16 |
62,513 |
Premium* |
|
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
|
0 |
2014-03-19 |
0 |
Premium* |
|
Orexigen Therapeutics, Inc. |
OREX |
10% Owner |
2007-11-27 |
15,096 |
2011-12-22 |
50,643 |
Premium* |
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2010-04-27 |
0 |
2011-06-02 |
40,790 |
Premium* |
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
|
0 |
2013-01-18 |
244,057 |
Premium* |
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2010-11-29 |
0 |
2011-09-16 |
169,251 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
0 |
2011-11-21 |
51,013 |
Premium* |
|
Durata Therapeutics, Inc. |
DRTX |
10% Owner |
|
0 |
2012-07-24 |
22,306 |
Premium* |
|
Esperion Therapeutics, Inc. |
ESPR |
10% Owner |
|
0 |
2013-07-01 |
35,253 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2013-07-15 |
0 |
2013-07-15 |
1,920,730 |
Premium* |
|
Tobira Therapeutics Inc |
TBRA |
Director, 10% Owner |
|
0 |
2013-08-27 |
32,091 |
Premium* |
|
Evoke Pharma Inc |
EVOK |
10% Owner |
|
0 |
2013-09-30 |
24,256 |
Premium* |
|
Veracyte, Inc. |
VCYT |
Director |
2019-03-04 |
1,642 |
2019-03-04 |
1,641 |
Premium* |
|
Tandem Diabetes Care Inc |
TNDM |
Director, 10% Owner |
2013-11-19 |
0 |
2013-11-19 |
54,390 |
Premium* |
|
Dicerna Pharmaceuticals Inc |
DRNA |
10% Owner |
2014-02-04 |
0 |
2014-02-04 |
13,004 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
2014-03-17 |
0 |
2014-03-17 |
33,890 |
Premium* |
|
Aldeyra Therapeutics, Inc. |
ALDX |
Director |
2019-03-26 |
0 |
2019-03-26 |
8,763 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
157 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
28,928 |
29,471 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-07-08 |
4 |
B |
$1.05 |
$312,766 |
I/I |
297,872 |
14,740 |
2.1 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-07-08 |
4/A |
A |
$1.05 |
$312,766 |
I/I |
297,872 |
14,740 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-07-23 |
4 |
B |
$7.50 |
$4,875,000 |
I/I |
650,000 |
19,138 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-08-11 |
4 |
B |
$7.60 |
$792,680 |
I/I |
104,300 |
20,887 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-08-12 |
4 |
B |
$8.00 |
$3,200,000 |
I/I |
400,000 |
27,595 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-08-13 |
4 |
B |
$7.85 |
$102,050 |
I/I |
13,000 |
27,813 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-08-14 |
4 |
B |
$8.00 |
$209,800 |
I/I |
26,225 |
28,253 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-08-17 |
4 |
B |
$7.64 |
$482,856 |
I/I |
63,201 |
29,313 |
1.5 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,044 |
43,174 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-10 |
4 |
B |
$6.93 |
$584,892 |
I/I |
84,400 |
30,959 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-11 |
4 |
B |
$6.93 |
$371,448 |
I/I |
53,600 |
31,858 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-12 |
4 |
B |
$6.90 |
$427,800 |
I/I |
62,000 |
32,898 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-20 |
4 |
B |
$6.93 |
$1,732,500 |
I/I |
250,000 |
37,090 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-23 |
4 |
B |
$6.93 |
$1,039,500 |
I/I |
150,000 |
39,606 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-24 |
4 |
B |
$6.75 |
$337,500 |
I/I |
50,000 |
40,445 |
1.5 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-12-10 |
4 |
S |
$1.15 |
$66,125 |
I/I |
(57,500) |
14,131 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-12-11 |
4 |
S |
$1.15 |
$469,200 |
I/I |
(408,000) |
9,806 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-12-14 |
4 |
S |
$1.15 |
$40,250 |
I/I |
(35,000) |
9,435 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-12-17 |
4 |
B |
$7.55 |
$755,000 |
I/I |
100,000 |
42,122 |
1.5 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-12-17 |
4 |
S |
$1.04 |
$848,944 |
I/I |
(816,292) |
0 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-12-18 |
4 |
B |
$7.50 |
$285,750 |
I/I |
38,100 |
42,761 |
1.5 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-12-18 |
4 |
S |
$1.10 |
$88,521 |
I/I |
(80,474) |
0 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
9,144 |
52,318 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2010-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,371 |
53,689 |
0 |
- |
|
157 Records found
|
|
Page 4 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|